NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index.
The underlying index was composed of common stocks ofU. S. biotechnology and genome companies.
These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 7.62% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 5.70% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 5.40% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 5.26% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 5.04% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 5.01% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 4.79% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 4.78% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 4.73% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 4.67% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 4.22% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 3.73% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.55% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 3.48% |
| COLL | Collegium Pharmaceutical Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.46% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 3.42% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 3.40% |
| AVXL | Anavex Life Sciences Corp | Healthcare | Biotechnology | 3.34% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 3.32% |
| FOLD | Amicus Therapeutics Inc | Healthcare | Biotechnology | 3.14% |